Tag: prostate cancer

March 22, 2024

Tens of thousands of prostate cancer cases were missed during the disruption of the COVID pandemic. Those are the findings of a new study published in BJU International last month. Researchers from the University of Oxford and other U.K. universities […]

June 15, 2022

Prostate cancer is the most common cancer among men in the United States. Many patients can live long lives due to early detection and treatment with androgen deprivation therapy. However, despite the benefits of this therapy, almost all patients will […]

May 26, 2022

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy — a commonly used hormone injection — plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The […]

April 4, 2022

Prostate cancers remain localised in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, resulting in approximately 5,000 deaths each year in Austria alone. Medical research has […]

October 6, 2021

On 21 September, the US Food and Drug Administration (FDA) authorised Paige Prostate, the first artificial intelligence (AI) based software designed to detect areas at risk of being cancerous in prostate biopsy images. This software allows pathologists to make a […]

September 13, 2021

The risk of prostate cancer was 24% higher among 9/11 rescue and recovery workers after the attacks on the World Trade Center in 2001, with the highest risk among the earliest responders, finds research published online in the journal Occupational […]

December 7, 2020

Findings UCLA Jonsson Comprehensive Cancer Center researchers studying cancer evolution have created a framework to help determine which tool combinations are best for pinpointing the exact timing of DNA mutations in cancer genomes. There are currently many different algorithms that […]

May 28, 2020

The test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo distinct but subtle changes when cancer is present in the body. Particular types of glycans […]

December 19, 2019

Researchers at the University of Illinois, US have developed a method to detect microRNA cancer biomarkers with single-molecule resolution. The technique, Photonic Resonator Absorption Microscopy (PRAM), captures and counts cancer-associated microRNAs, known biomarkers for prostate cancer. The research team, led […]

October 18, 2019

Despite longstanding and earnest endeavors to develop new remedies, the prognosis of most glioblastoma patients undergoing chemotherapies and radiotherapies remains poor. Glioblastoma, a malignant glioma, has a median survival period of approximately 15 months. One of the reasons for this […]

December 3, 2018

Conducted by Chris O’Brien Lifehouse and Garvan Institute of Medical Research, the study involved the analysis of blood samples for a methylated copy of the glutathione S-transferase gene (mGSTP1) both before and during treatment. At the beginning of the study, […]

July 31, 2018

Various mechanisms exist for cells to communicate with each other, and many are essential for development. A team of international researchers looked at how one important family of signalling molecules — Wnt proteins, which orchestrate and control many cell development […]

June 18, 2018

A 6-year research project identifies 63 gene changes that could help to indicate an increased risk of prostate cancer in certain men. The study was conducted at Case Western Reserve University School of Medicine in Cleveland, OH, and the results […]

January 27, 2017

RAISED levels of a tiny molecule in the bloodstream have been linked with prostate cancer metastasis, potentially helping researchers detect the spread of the disease sooner. A multi-institutional research team led by the University of Adelaide in South Australia has […]

June 29, 2016

Prostate cancer researchers have discovered biomarkers using non-invasive liquid biopsies to identify aggressive disease before surgery. The research, published online today in Nature Communications, advances the quest to develop a precise, non-invasive diagnostic tool that can address the worldwide clinical […]

May 16, 2016

Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients who have a […]